Kentucky launches center for cancer and metabolism research
The University Of Kentucky has been awarded an $11.2 million prestigious Centers of Biomedical Research Excellence (COBRE) grant to assist with the study of cancer and metabolism.
The grant was received from the National Institutes of General Medical Sciences and will fund the research and development project for the next 5 years.
The project aims to discover and prove a direct link between obesity and cancer. The need for research into this field is of high necessity, particularly for Kentuckians. Kentucky has disproportionately high incidences of both cancer and metabolic disorders and currently leads the nation in cancer deaths and obesity rates.
The University of Kentucky and its Markey Cancer Center have developed one of the strongest cancer research, prevention and treatment programs in the country. The awarding of the competitive grant is recognition of the University being a national leader in biomedical research.
Kentucky’s Center for Cancer and Metabolism (CCM) capitalizes on highly specialized institutional strengths in cancer and advancement metabolomics tools. This research focuses on the underlying mechanisms that link dysfunctional metabolism to cancer. Recent studies have shown that Mitochondria, the metabolic powerhouse of cells, can influence how aggressive a cancer becomes.
Research and development is at the core of economic and human development and it is why the University of Kentucky is the state’s instrumental change agent, health provider and economic engine.
The importance of the following R&D grant is largely significant to Kentucky, as the synergy and collaboration between researchers and clinicians to further studies in cancer could not be carried out without them.
To find out more about R&D or to determine whether your business is eligible for Kentucky’s .395 Research Facilities Tax Credit, contact a Swanson Reed R&D tax specialist.
